Transasia launches new generation haematology analyser

EHM News Bureau - Mumbai

In a yet another effort to bring the best and latest technology to their customers, Transasia Biomedical Ltd recently launched haematology analyser, SYSMEX XT 2000i and 1800i in India in collaboration with Sysmex Corporation Japan.

Sysmex XT series is a cutting edge technology and considerably improves the quality of reports generated from the blood samples due to the innovative principle of fluorescence-based flowcytometry. This principle involves the staining of the white blood cells and then counting using semi conductor laser diffraction.

With over 250 installations in the European market and around 50 instruments in the Asia -Pacific market within nine months of the launch, the XT series has proven to be a versatile and reliable analyser.

This instrument has two models the XT 2000i (with Reticulocyte count) and XT1800i (without Reticulocyte count). The instrument is linked to an external powerful Pentium 4 based Data station, which makes the data analysis very accurate. The XT series has a high throughput of 80 samples per hour and the reports are printed through the data station on to a colour printer.

The instrument is a true random access fully automatic analyser, which has upto four different analysis modes namely 1.CBC 2. CBC+DIFF 3. CBC+DIFF+RET 4. CBC+RET.

The XT series has extensive QC programs inbuilt with facility to store upto 21 files of QC with 300 points in each file. This helps the pathologist/haematologist to ensure that each report going out of his instrument has high reliability.

The external data station store upto 10,000 results with graphics, 5000 patient demographics and 1000 orders in memory. The XT system has futuristic needs of intra and Internet capabilities also catered for in itself.

Eminent haematologists, Prof Dr M B Agarwal and Prof S K Sood, emphasised the need for automation in haematology at the launch of the product. The managing director Transasia Bio-Medicals Ltd, S Vazirani said, "Transasia would continue to give the best in clinical automation to facilitate better diagnosis and hence better cure for maladies for the people of India."

For two decades Transasia Biomedical Limited have been consistently catering to the needs of millions of patients by facilitating precise and accurate diagnosis of illnesses.

Experts emphasised that XT - 2000i is an ideal analyser to meet the requirements of a medium size hospital or laboratory. They also highlighted how this system could reduce recurring cost, thereby making blood analysis affordable to the masses. The fluorescence-based flow cytometry; the latest technology that brings about flawless separation between pathological and normal blood samples, used in the analyser give the physicians a clear-cut picture of the patient’s haematological Status.

XT - 2000i represents the next generation in haematology analysers and truly a 21st Century laboratory management concept - an unusual combination of IT and technology, which will revolutionalise the science of blood cell analysis.